Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2618178766;78767;78768 chr2:178567591;178567590;178567589chr2:179432318;179432317;179432316
N2AB2454073843;73844;73845 chr2:178567591;178567590;178567589chr2:179432318;179432317;179432316
N2A2361371062;71063;71064 chr2:178567591;178567590;178567589chr2:179432318;179432317;179432316
N2B1711651571;51572;51573 chr2:178567591;178567590;178567589chr2:179432318;179432317;179432316
Novex-11724151946;51947;51948 chr2:178567591;178567590;178567589chr2:179432318;179432317;179432316
Novex-21730852147;52148;52149 chr2:178567591;178567590;178567589chr2:179432318;179432317;179432316
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: P
  • RefSeq wild type transcript codon: CCA
  • RefSeq wild type template codon: GGT
  • Domain: Fn3-78
  • Domain position: 94
  • Structural Position: 126
  • Q(SASA): 0.5179
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
P/L rs1467251247 None 0.1 N 0.581 0.341 0.376745185316 gnomAD-4.0.0 1.603E-06 None None None None N None 0 0 None 0 0 None 0 0 2.88206E-06 0 0
P/T None None 0.1 N 0.507 0.141 0.171388866994 gnomAD-4.0.0 1.20032E-06 None None None None N None 0 0 None 0 0 None 0 0 1.3125E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
P/A 0.0735 likely_benign 0.0853 benign -0.667 Destabilizing None N 0.239 neutral N 0.486005732 None None N
P/C 0.5171 ambiguous 0.5671 pathogenic -0.696 Destabilizing 0.887 D 0.648 neutral None None None None N
P/D 0.6962 likely_pathogenic 0.7691 pathogenic -0.173 Destabilizing 0.128 N 0.494 neutral None None None None N
P/E 0.4605 ambiguous 0.546 ambiguous -0.258 Destabilizing 0.001 N 0.251 neutral None None None None N
P/F 0.5405 ambiguous 0.6131 pathogenic -0.668 Destabilizing 0.676 D 0.658 prob.neutral None None None None N
P/G 0.4629 ambiguous 0.5371 ambiguous -0.851 Destabilizing 0.057 N 0.465 neutral None None None None N
P/H 0.3738 ambiguous 0.4484 ambiguous -0.293 Destabilizing 0.676 D 0.608 neutral None None None None N
P/I 0.3553 ambiguous 0.4245 ambiguous -0.317 Destabilizing 0.507 D 0.689 prob.delet. None None None None N
P/K 0.6045 likely_pathogenic 0.697 pathogenic -0.532 Destabilizing 0.128 N 0.503 neutral None None None None N
P/L 0.1943 likely_benign 0.246 benign -0.317 Destabilizing 0.1 N 0.581 neutral N 0.467561263 None None N
P/M 0.3615 ambiguous 0.4327 ambiguous -0.374 Destabilizing 0.887 D 0.609 neutral None None None None N
P/N 0.5364 ambiguous 0.624 pathogenic -0.287 Destabilizing 0.227 N 0.601 neutral None None None None N
P/Q 0.3173 likely_benign 0.3962 ambiguous -0.504 Destabilizing 0.28 N 0.558 neutral N 0.483921226 None None N
P/R 0.4752 ambiguous 0.5689 pathogenic -0.009 Destabilizing 0.437 N 0.643 neutral N 0.490669175 None None N
P/S 0.1807 likely_benign 0.2318 benign -0.747 Destabilizing 0.004 N 0.238 neutral N 0.47369537 None None N
P/T 0.1657 likely_benign 0.2179 benign -0.724 Destabilizing 0.1 N 0.507 neutral N 0.487624672 None None N
P/V 0.254 likely_benign 0.3071 benign -0.397 Destabilizing 0.128 N 0.537 neutral None None None None N
P/W 0.7628 likely_pathogenic 0.8106 pathogenic -0.738 Destabilizing 0.96 D 0.681 prob.neutral None None None None N
P/Y 0.557 ambiguous 0.6377 pathogenic -0.451 Destabilizing 0.864 D 0.659 prob.neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.